{"id":"vehicle-base-cream","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108947","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The base cream is used as a vehicle for other topical medications, providing a delivery system for active ingredients.","oneSentence":"This drug serves as a base cream for vehicle purposes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:40:20.846Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07482787","phase":"PHASE3","title":"Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa","status":"NOT_YET_RECRUITING","sponsor":"Paradigm Therapeutics","startDate":"2026-05-15","conditions":"Epidermolysis Bullosa (EB)","enrollment":80},{"nctId":"NCT07301515","phase":"NA","title":"Randomised Controlled Trial of an Antioxidant and Sunscreen Combination Cream for Reducing DNA Damage in Human Skin","status":"COMPLETED","sponsor":"Klira Skin","startDate":"2025-03-01","conditions":"Photoaging, Photodamage, Mitochondrial Damage","enrollment":52},{"nctId":"NCT06807021","phase":"PHASE2, PHASE3","title":"Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients","status":"RECRUITING","sponsor":"Birch BioMed Inc","startDate":"2025-12-01","conditions":"Burn Scar, Burn Wound","enrollment":70},{"nctId":"NCT05860881","phase":"PHASE3","title":"Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Melanoma and Skin Cancer Trials Limited","startDate":"2024-02-09","conditions":"Solid Organ Transplant Recipients, Skin Cancer","enrollment":146},{"nctId":"NCT06531512","phase":"PHASE2, PHASE3","title":"Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers","status":"RECRUITING","sponsor":"Oneness Biotech Co., Ltd.","startDate":"2024-08-16","conditions":"Diabetic Foot Ulcer","enrollment":120},{"nctId":"NCT02376049","phase":"PHASE1","title":"A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-02","conditions":"Atopic Dermatitis","enrollment":30},{"nctId":"NCT04435392","phase":"PHASE1, PHASE2","title":"Jaktinib Hydrochloride Cream For Atopic Dermatitis","status":"COMPLETED","sponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","startDate":"2020-10-14","conditions":"Atopic Dermatitis","enrollment":107},{"nctId":"NCT05984420","phase":"NA","title":"Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis","status":"UNKNOWN","sponsor":"Aileens Pharma SRL","startDate":"2022-04-21","conditions":"Atopic Dermatitis","enrollment":200},{"nctId":"NCT05971355","phase":"NA","title":"Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis","status":"UNKNOWN","sponsor":"Aileens Pharma SRL","startDate":"2021-03-10","conditions":"Atopic Dermatitis","enrollment":200},{"nctId":"NCT04908215","phase":"PHASE2","title":"INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa","status":"COMPLETED","sponsor":"InMed Pharmaceuticals Inc.","startDate":"2021-12-28","conditions":"Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, Junctional, Epidermolysis Bullosa Dystrophica","enrollment":19},{"nctId":"NCT05488990","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis","status":"COMPLETED","sponsor":"Lipidor AB","startDate":"2013-03-25","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT04016025","phase":"PHASE4","title":"A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers","status":"COMPLETED","sponsor":"Jena University Hospital","startDate":"2020-12-02","conditions":"Adherence, Patient, Chronic Eczema","enrollment":80},{"nctId":"NCT02240407","phase":"PHASE1","title":"Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease","status":"COMPLETED","sponsor":"University of Florida","startDate":"2017-10-17","conditions":"Pompe Disease","enrollment":2},{"nctId":"NCT04169438","phase":"NA","title":"Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions","status":"COMPLETED","sponsor":"The Center for Clinical and Cosmetic Research","startDate":"2019-11-05","conditions":"Wound Heal, Scar, Keloid","enrollment":10},{"nctId":"NCT04635254","phase":"NA","title":"The Effect of Halophyte-based Cream on Pain and Itch","status":"COMPLETED","sponsor":"Aalborg University","startDate":"2020-11-12","conditions":"Pain, Acute, Itch","enrollment":32},{"nctId":"NCT03846648","phase":"PHASE1","title":"CyPep-1 in Cutaneous Warts","status":"COMPLETED","sponsor":"Centre for Human Drug Research, Netherlands","startDate":"2019-03-11","conditions":"Cutaneous Warts","enrollment":56},{"nctId":"NCT02601105","phase":"NA","title":"Topical Centella Asiatica and the Cosmetic Appearance of Stretch Marks","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2014-10","conditions":"Stretch Marks, Striae Distensae, Cosmetic Appearance of Stretch Marks","enrollment":15},{"nctId":"NCT03096457","phase":"PHASE2, PHASE3","title":"Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia","status":"COMPLETED","sponsor":"Fundacion Nacional de Dermatologia","startDate":"2017-04-15","conditions":"Leishmaniasis, Cutaneous, Leishmania Braziliensis Complex, Leishmaniasis, American","enrollment":80},{"nctId":"NCT04586816","phase":"NA","title":"Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging","status":"COMPLETED","sponsor":"Integrative Skin Science and Research","startDate":"2019-09-10","conditions":"Photoaging, Hyperpigmentation, Rhytides","enrollment":19},{"nctId":"NCT02710981","phase":"NA","title":"Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-06","conditions":"Anovulation","enrollment":42},{"nctId":"NCT02014376","phase":"PHASE2","title":"Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa","status":"COMPLETED","sponsor":"Scioderm, Inc.","startDate":"2014-01-06","conditions":"Epidermolysis Bullosa","enrollment":48},{"nctId":"NCT04186273","phase":"PHASE2","title":"Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2.","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2019-12-05","conditions":"Scar, Cicatrix, Hypertrophic Scar","enrollment":50},{"nctId":"NCT01567995","phase":"PHASE3","title":"Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-02-28","conditions":"Eczema","enrollment":240},{"nctId":"NCT02564055","phase":"PHASE2","title":"A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-12-01","conditions":"Dermatitis, Atopic","enrollment":247},{"nctId":"NCT02564042","phase":"PHASE2","title":"A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-11-23","conditions":"Psoriasis","enrollment":227},{"nctId":"NCT03144193","phase":"NA","title":"Efficacy in Daily Use of a Novel Skin Care Product for the Treatment of Photoaged Skin","status":"UNKNOWN","sponsor":"University of Manchester","startDate":"2017-06-01","conditions":"Photoaging","enrollment":60},{"nctId":"NCT00470392","phase":"NA","title":"Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2007-05","conditions":"Psoriasis","enrollment":9},{"nctId":"NCT02689856","phase":"PHASE2","title":"Safety and Efficacy of Hydrocortisone and Lidocaine Treatment of Grade I and II Hemorrhoids","status":"COMPLETED","sponsor":"Citius Pharmaceuticals, Inc.","startDate":"2015-05","conditions":"Hemorrhoids","enrollment":211},{"nctId":"NCT01772056","phase":"PHASE3","title":"Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children","status":"TERMINATED","sponsor":"Elena Rubio Gomis","startDate":"2009-12","conditions":"Dermatitis, Atopic","enrollment":54},{"nctId":"NCT00606580","phase":"PHASE3","title":"Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2008-01","conditions":"Cutaneous Leishmaniasis","enrollment":375},{"nctId":"NCT00124709","phase":"PHASE4","title":"Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2003-10","conditions":"Atopic Dermatitis","enrollment":1091}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":16,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Vehicle (base cream)","genericName":"Vehicle (base cream)","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vehicle, a base cream, has been used as a control in clinical trials for various skin conditions, including Atopic Dermatitis, Cutaneous Leishmaniasis, Diabetic Foot Ulcer, and Cutaneous Warts. The exact mechanism of action of Vehicle is unknown, as it is classified as a base cream with no specific modality.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}